Tropicamide

Known as: Tropicamid, Tropicamida, Tropimil 
A synthetic muscarinic antagonist with actions similar to atropine and with an anticholinergic property. Upon ocular administration, tropicamide… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
The purpose of this study was to determine the influence of a controlled incremental increase in size, molecular weight and… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The contributions of separate sympathetic and parasympathetic pathways to pupillary dilation during a sustained processing task… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE To examine baseline measurements of accommodative lag, phoria, reading distance, amount of near work, and level of myopia… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE The purpose of the Correction of Myopia Evaluation Trial (COMET) was to evaluate the effect of progressive addition… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2003
2003
Diagnostic tests for Alzheimer's disease (AD) involving tropicamide blockade of cholinergic oculomotor functions were examined in… (More)
Is this relevant?
2001
2001
PURPOSE To evaluate the cycloplegic effect of 1% tropicamide in myopic children and to determine whether its efficacy is… (More)
Is this relevant?
1999
1999
Tropicamide, a mydriatic, cycloplegic drug was entrapped in liposomes. Liposomes were investigated by laser counting studies… (More)
Is this relevant?
1998
1998
Thirty-seven myopic children were given either 1-2 drops of 1% cyclopentolate or 1% tropicamide twice with 5 min intervals to… (More)
Is this relevant?
1993
1993
This double masked study compares the cycloplegic effects of tropicamide 1% and cyclopentolate 1% in 20 nonstrabismic… (More)
Is this relevant?
1986
1986
The time course of accommodative loss after the topical application of 0.5% and 1.0% concentrations of cyclopentolate HCl and… (More)
Is this relevant?